Somatic mutations in peroxisome proliferator-activated receptor-γ are rare events in human cancer cells

Medical Science Monitor

Volumn 10, Issue 8, 2004, Pages

  Posch, Maximilian G ^a   Zang, Chuanbing ^a   Mueller, Wolf ^a   Lass, Ulrike ^a   Von Deimling, Andreas ^a   Elstner, Elena ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Breast cancer; Glioblastoma; Leukemia; PPAR gamma; SSCP

Indexed keywords

AMINO ACID; DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ARTICLE; CANCER CELL; DNA SEQUENCE; GENE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION; WESTERN BLOTTING;

BRAIN NEOPLASMS; BREAST NEOPLASMS; DNA PRIMERS; FEMALE; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR CELLS, CULTURED;

EID: 4444338621     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kim JB, Spiegelman BM: ADD1/SREBP1 Promotes Adipocyte Differentiation and Gene Expression Linked to Fatty Acid Metabolism. Genes Dev, 1996; 10(9): 1096-107
2. Pasceri V, Wu HD, Willerson JT, Yeh ET: Modulation of Vascular Inflammation in Vitro and in Vivo by Peroxisome Proliferator-Activated Receptor-Gamma Activators. Circulation, 2000; 101(3): 235-38
3. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM et al: PPARalpha and PPARgamma Activators Direct a Distinct Tissue-Specific Transcriptional Response Via a PPRE in the Lipoprotein Lipase Gene. EMBO J, 1996; 15(19): 5336-48
4. Martin G, Schoonjans K, Lefebvre A et al: Coordinate Regulation of the Expression of the Fatty Acid Transport Protein and Acyl-CoA Synthetase Genes by PPARalpha and PPARgamma Activators. J Biol Chem, 1997; 272(45): 28210-17
5. Gupta RA, Brockman JA, Sarraf P et al: Target Genes of Peroxisome Proliferator-Activated Receptor Gamma in Colorectal Cancer Cells. J Biol Chem, 2001; 276(32): 29681-87
6. Elstner E, Williamson EA, Zang C et al: Novel Therapeutic Approach: Ligands for PPARgamma and Retinoid Receptors Induce Apoptosis in Bcl-2-Positive Human Breast Cancer Cells. Breast Cancer Res Treat, 2002; 74(2): 155-65
7. Zang C, Wachter M, Liu H et al: Ligands for PPARgamma and RAR Cause Induction of Growth Inhibition and Apoptosis in Human Glioblastomas. J Neurooncol, 2003; 65(2): 107-18
8. Liu H, Zang C, Fenner MH et al: PPARgamma Ligands and ATRA Inhibit the Invasion of Human Breast Cancer Cells in Vitro. Breast Cancer Res Treat, 2003; 79(1): 63-74
9. Elstner E, Muller C, Koshizuka K et al: Ligands for Peroxisome Proliferator-Activated Receptorgamma and Retinoic Acid Receptor Inhibit Growth and Induce Apoptosis of Human Breast Cancer Cells in Vitro and in BNX Mice. Proc Natl Acad Sci U.S.A., 1998; 95(15): 8806-11
10. Mueller E, Smith M, Sarraf P et al: Effects of Ligand Activation of Peroxisome Proliferator-Activated Receptor Gamma in Human Prostate Cancer. Proc Natl Acad Sci U.S.A., 2000; 97(20): 10990-95
11. Kulke MH, Demetri GD, Sharpless NE et al: A Phase II Study of Troglitazone, an Activator of the PPARgamma Receptor, in Patients With Chemotherapy-Resistant Metastatic Colorectal Cancer. Cancer J, 2002; 8(5): 395-99
12. Sarraf P, Mueller E, Smith WM et al: Loss-of-Function Mutations in PPAR Gamma Associated With Human Colon Cancer. Mol Cell, 1999; 3(6): 799-804
13. Ikezoe T, Miller CW, Kawano S et al: Mutational Analysis of the Peroxisome Proliferator-Activated Receptor Gamma Gene in Human Malignancies. Cancer Res, 2001; 61(13): 5307-10
14. Burstein HJ, Demetri GD, Mueller E et al: Use of the Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Ligand Troglitazone As Treatment for Refractory Breast Cancer: a Phase II Study. Breast Cancer Res Treat, 2003; 79(3): 391-97
15. Zhou XP, Smith WM, Gimm O, et al: Over-Representation of PPARgamma Sequence Variants in Sporadic Cases of Glioblastoma Multiforme: Preliminary Evidence for Common Low Penetrance Modifiers for Brain Tumour Risk in the General Population. J Med Genet, 2000; 37(6): 410-14
16. Bender B, Wiestler OD, von Deimling AA: Device for Processing Large Acrylamide Gels. Biotechniques, 1994; 16(2): 204-6
17. Yen CJ, Beamer BA, Negri C et al: Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor Gamma (HPPAR Gamma) Gene in Diabetic Caucasians: Identification of a Pro12A1a PPAR Gamma 2 Missense Mutation. Biochem Biophys Res Commun, 1997; 241(2): 270-74
18. Murata T, He S, Hangai M et al: Peroxisome Proliferator-Activated Receptor-Gamma Ligands Inhibit Choroidal Neovascularization. Invest Ophthalmol Vis Sci, 2000; 41(8): 2309-17
19. Nwankwo JO, Robbins ME: Peroxisome Proliferator-Activated Receptor-Gamma Expression in Human Malignant and Normal Brain, Breast and Prostate-Derived Cells. Prostaglandins Leukot Essent Fatty Acids, 2001; 64(4-5): 241-45
20. Saez E, Tontonoz P, Nelson MC et al: Activators of the Nuclear Receptor PPARgamma Enhance Colon Polyp Formation. Nat Med, 1998; 4(9): 1058-61
21. Konturek PC, Kania J, Konturek JW et al: Pylori Infection, Atrophic Gastritis, Cytokines, Gastrin, COX-2, PPAR Gamma and Impaired Apoptosis in Gastric Carcinogenesis. Med Sci Monit, 2003; 9(7): SR53-SR66
22. Marques AR, Espadinha C, Catarino AL et al: Expression of PAX8-PPAR Gamma 1 Rearrangements in Both Follicular Thyroid Carcinomas and Adenomas. J Clin Endocrinol Metab, 2002; 87(8): 3947-52
23. Martelli ML, Iuliano R, Le Pera I et al: Inhibitory Effects of Peroxisome Poliferator-Activated Receptor Gamma on Thyroid Carcinoma Cell Growth. J Clin Endocrinol Metab, 2002; 87(10): 4728-35